SanofiFrom Sanofi - Page 2Sanofi recharges Nasacort with package redesignFDA Approves $37,000/Yr Eczema DrugSanofi Takes on Rituximab in Asian Biosimilar MarketReturn of EpiPen RivalSanofi study reveals perceptions of counterfeit medicinesSanofi Study Reveals Perceptions of Counterfeit MedicinesSanofi Study Reveals Perceptions of Counterfeit MedicinesSanofi Chattem uses package design to launch Icy Hot Smart ReliefIcy Hot Smart Relief employs wireless deviceIcy Hot Smart Relief employs wireless deviceSanofi Chattem uses package design to launch Icy Hot Smart ReliefSanofi’s Nasacort® Allergy 24HR booklet pack with thermoform delivers ‘wow’ factorPrevious PagePage 2 of 2